Imidazolo-oxindole PKR inhibitor C16
SIGMA/I9785 - ≥98% (HPLC)
Synonym: 6,8-
CAS Number: 608512-97-6
Empirical Formula (Hill Notation): C13H8N4OS
Molecular Weight: 268.29
MDL Number: MFCD06735404
Linear Formula: C13H8N4OS
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow to orange-brown |
| InChI | 1S/C13H8N4OS/c18-13-8(3-7 |
| InChI key | VFBGXTUGODTSPK-BAQGIRSFSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | O=C1NC2=CC=C3C(SC=N3)=C2/ |
| solubility | DMSO: 12 mg/mL |
| storage temp. | −20°C |
| Application: | Imidazolo-oxindole PKR inhibitor C16 has been used: • to rescue fear memory deficits and restore long-term potentiation (LTP) impairment in mice • to inhibit the strong induction of interferon stimulated genes (ISGs) after plasmid transfection in HeLa-S3 cells • to augment eukaryotic translation initiation factor 2 (eIF2) activity |
| Biochem/physiol Actions: | C16 exhibits a neuroprotective role in adult brain injuries. |
| Biochem/physiol Actions: | Imidazolo-oxindole PKR inhibitor C16 is a selectiv inhibitor of RNA-dependent protein kinases (PKR, Eif2ak2). |
| Biochem/physiol Actions: | Imidazolo-oxindole PKR inhibitor C16 is a selective inhibitor of RNA-dependent protein kinases (PKR, Eif2ak2). C16 is a first reported, potent and selective PKR inhibitor. Its inhibition effect on PKR is ATP-binding site directed. C16 specifically inhibits the apoptotic PKR/eIF2a signaling pathway without stimulating the proliferative mTOR/p70S6K signaling mechanism. |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

